Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostate Cancer Patients × Bupropion × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Advanced Solid Tumor 2 Smoking 1 Prostate Cancer Patients 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Healthy Adult Participants 1 Head and Neck Neoplasms 1

Interventions

repaglinide 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04664725 2020-12-11

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown

Prostate Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡